Bufuralol is a potent beta-adrenoceptor antagonist with partial agonist activity that has historically been used to treat hypertension and angina pectoris by blocking sympathetic stimulation of the heart.… Read more






![Chemical structure of 3-Tert-Butyl-5-[7-(Hydroxyethyl)-2-benzofuranyl]-2-oxazolidinone(Mixture of Diastereomers)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1076199-70-6-3-Tert-Butyl-5-7-Hydroxyethyl-2-benzofuranyl-2-oxazolidinoneMixture-of-Diastereomers.png&w=3840&q=75)



Bufuralol is a potent beta-adrenoceptor antagonist with partial agonist activity that has historically been used to treat hypertension and angina pectoris by blocking sympathetic stimulation of the heart. Because this drug is extensively metabolized by the CYP2D6 enzyme, pharmaceutical laboratories rely on high-quality reference standards for accurate analytical testing and method validation. This category includes the active pharmaceutical ingredient, along with essential pharmacopeial and non-pharmacopeial impurities, such as specific hydroxylated and oxo-derivatives, and N-nitroso compounds. Researchers also utilize stable isotope labelled compounds as internal standards to ensure precision during impurity profiling and pharmacokinetic studies. By providing access to these key degradation products and metabolites, this collection supports rigorous quality control and developmental research surrounding the drug substance.